Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Capricor Therapeutics (CAPR) Prepaid Assets (2016 - 2025)

Historic Prepaid Assets for Capricor Therapeutics (CAPR) over the last 17 years, with Q3 2025 value amounting to $2.3 million.

  • Capricor Therapeutics' Prepaid Assets rose 50419.49% to $2.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.3 million, marking a year-over-year increase of 50419.49%. This contributed to the annual value of $1.5 million for FY2024, which is 5072.68% up from last year.
  • As of Q3 2025, Capricor Therapeutics' Prepaid Assets stood at $2.3 million, which was up 50419.49% from $1.3 million recorded in Q2 2025.
  • In the past 5 years, Capricor Therapeutics' Prepaid Assets registered a high of $2.3 million during Q3 2025, and its lowest value of $278909.0 during Q3 2021.
  • Its 5-year average for Prepaid Assets is $919128.0, with a median of $875092.0 in 2023.
  • As far as peak fluctuations go, Capricor Therapeutics' Prepaid Assets plummeted by 2069.47% in 2022, and later soared by 50419.49% in 2025.
  • Quarter analysis of 5 years shows Capricor Therapeutics' Prepaid Assets stood at $1.2 million in 2021, then decreased by 20.69% to $919892.0 in 2022, then grew by 8.25% to $995776.0 in 2023, then skyrocketed by 50.73% to $1.5 million in 2024, then surged by 55.01% to $2.3 million in 2025.
  • Its Prepaid Assets was $2.3 million in Q3 2025, compared to $1.3 million in Q2 2025 and $1.4 million in Q1 2025.